Company profile: MedAvante-ProPhase
1.1 - Company Overview
Company description
- Provider of technology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MedAvante-ProPhase
Antibodies Online
HQ: Germany
Website
- Description: Provider of a vendor-independent marketplace for antibodies, ELISA kits, and related research reagents, offering more than 1.2 million products from over 160 suppliers. Portfolio includes primary (polyclonal, monoclonal, recombinant) and secondary antibodies, lateral flow antibodies, ELISA kits, recombinant proteins, and custom antibody services with Rockland Immunochemicals, Inc., serving 2,000+ companies and research institutions in 53 countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Antibodies Online company profile →
BioWisdom
HQ: United Kingdom
Website
- Description: Provider of software tools and intelligence services for the healthcare industry, enabling acquisition, integration, visualization, and high-value analysis of healthcare intelligence to help clients navigate complex scientific and commercial issues in developing successful healthcare products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioWisdom company profile →
Aparito
HQ: United Kingdom
Website
- Description: Provider of an eCOA platform (Atom5) that digitises clinical trials and captures real-world patient data via video assessments, ePROs, wearables, telemedicine, and eConsent, delivering real-time insights to clinical teams. Part 11, GDPR and HIPPA compliant, supporting patient-centric trials at scale in 193 countries and 125 languages.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aparito company profile →
Medrio
HQ: United States
Website
- Description: Provider of advanced electronic data capture (EDC) and e-clinical tools for complex clinical trials, offering real-time data access via dynamic reports, exports, and automated casebooks; supply chain optimization for coordinated dispensing aligned with manufacturing, packaging, labeling, and logistics; participant comprehension and engagement solutions; services to accelerate study timelines and improve clinical data integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medrio company profile →
Lab Unlimited
HQ: Ireland
Website
- Description: Provider of laboratory instrumentation, consumables, training, service, and validation, with an extensive catalogue available on its website backed by more than 400 manufacturers. Highly trained representatives can recommend solutions, replacements, and cost-saving options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lab Unlimited company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MedAvante-ProPhase
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MedAvante-ProPhase
2.2 - Growth funds investing in similar companies to MedAvante-ProPhase
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MedAvante-ProPhase
4.2 - Public trading comparable groups for MedAvante-ProPhase
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →